These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

377 related articles for article (PubMed ID: 17304514)

  • 1. IL-6 induces AGS gastric cancer cell invasion via activation of the c-Src/RhoA/ROCK signaling pathway.
    Lin MT; Lin BR; Chang CC; Chu CY; Su HJ; Chen ST; Jeng YM; Kuo ML
    Int J Cancer; 2007 Jun; 120(12):2600-8. PubMed ID: 17304514
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Gastrokine 1 inhibits gastric cancer cell migration and invasion by downregulating RhoA expression.
    Yoon JH; Choi WS; Kim O; Choi BJ; Nam SW; Lee JY; Park WS
    Gastric Cancer; 2017 Mar; 20(2):274-285. PubMed ID: 27250838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cyr61 induces gastric cancer cell motility/invasion via activation of the integrin/nuclear factor-kappaB/cyclooxygenase-2 signaling pathway.
    Lin MT; Zuon CY; Chang CC; Chen ST; Chen CP; Lin BR; Wang MY; Jeng YM; Chang KJ; Lee PH; Chen WJ; Kuo ML
    Clin Cancer Res; 2005 Aug; 11(16):5809-20. PubMed ID: 16115920
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MiR-31 Regulates Rho-Associated Kinase-Myosin Light Chain (ROCK-MLC) Pathway and Inhibits Gastric Cancer Invasion: Roles of RhoA.
    Chen Z; Liu S; Xia Y; Wu K
    Med Sci Monit; 2016 Dec; 22():4679-4691. PubMed ID: 27904131
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Nuclear factor-kappaB activation correlates with better prognosis and Akt activation in human gastric cancer.
    Lee BL; Lee HS; Jung J; Cho SJ; Chung HY; Kim WH; Jin YW; Kim CS; Nam SY
    Clin Cancer Res; 2005 Apr; 11(7):2518-25. PubMed ID: 15814628
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Macrophages stimulate gastric and colorectal cancer invasion through EGFR Y(1086), c-Src, Erk1/2 and Akt phosphorylation and smallGTPase activity.
    Cardoso AP; Pinto ML; Pinto AT; Oliveira MI; Pinto MT; Gonçalves R; Relvas JB; Figueiredo C; Seruca R; Mantovani A; Mareel M; Barbosa MA; Oliveira MJ
    Oncogene; 2014 Apr; 33(16):2123-33. PubMed ID: 23644655
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Reversal of the malignant phenotype of gastric cancer cells by inhibition of RhoA expression and activity.
    Liu N; Bi F; Pan Y; Sun L; Xue Y; Shi Y; Yao X; Zheng Y; Fan D
    Clin Cancer Res; 2004 Sep; 10(18 Pt 1):6239-47. PubMed ID: 15448013
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-32 increases human gastric cancer cell invasion associated with tumor progression and metastasis.
    Tsai CY; Wang CS; Tsai MM; Chi HC; Cheng WL; Tseng YH; Chen CY; Lin CD; Wu JI; Wang LH; Lin KH
    Clin Cancer Res; 2014 May; 20(9):2276-88. PubMed ID: 24602839
    [TBL] [Abstract][Full Text] [Related]  

  • 9. KITENIN is associated with tumor progression in human gastric cancer.
    Ryu HS; Park YL; Park SJ; Lee JH; Cho SB; Lee WS; Chung IJ; Kim KK; Lee KH; Kweon SS; Joo YE
    Anticancer Res; 2010 Sep; 30(9):3479-86. PubMed ID: 20944126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. STAT3 interacts with Skp2/p27/p21 pathway to regulate the motility and invasion of gastric cancer cells.
    Wei Z; Jiang X; Qiao H; Zhai B; Zhang L; Zhang Q; Wu Y; Jiang H; Sun X
    Cell Signal; 2013 Apr; 25(4):931-8. PubMed ID: 23333463
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Semaphorin 4D expression is associated with a poor clinical outcome in cervical cancer patients.
    Liu H; Yang Y; Xiao J; Yang S; Liu Y; Kang W; Li X; Zhang F
    Microvasc Res; 2014 May; 93():1-8. PubMed ID: 24603190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NET1-mediated RhoA activation facilitates lysophosphatidic acid-induced cell migration and invasion in gastric cancer.
    Murray D; Horgan G; Macmathuna P; Doran P
    Br J Cancer; 2008 Oct; 99(8):1322-9. PubMed ID: 18827818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. RhoA/ROCK and Cdc42 regulate cell-cell contact and N-cadherin protein level during neurodetermination of P19 embryonal stem cells.
    Laplante I; Béliveau R; Paquin J
    J Neurobiol; 2004 Sep; 60(3):289-307. PubMed ID: 15281068
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of RhoA/ROCK signaling pathway promotes the apoptosis of gastric cancer cells.
    Xu XT; Song QB; Yao Y; Ruan P; Tao ZZ
    Hepatogastroenterology; 2012; 59(120):2523-6. PubMed ID: 22584506
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IL-6 mediates the signal pathway of JAK-STAT3-VEGF-C promoting growth, invasion and lymphangiogenesis in gastric cancer.
    Zhao G; Zhu G; Huang Y; Zheng W; Hua J; Yang S; Zhuang J; Ye J
    Oncol Rep; 2016 Mar; 35(3):1787-95. PubMed ID: 26750536
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vincristine enhances amoeboid-like motility via GEF-H1/RhoA/ROCK/Myosin light chain signaling in MKN45 cells.
    Eitaki M; Yamamori T; Meike S; Yasui H; Inanami O
    BMC Cancer; 2012 Oct; 12():469. PubMed ID: 23057787
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Piperine inhibits IL-1β-induced IL-6 expression by suppressing p38 MAPK and STAT3 activation in gastric cancer cells.
    Xia Y; Khoi PN; Yoon HJ; Lian S; Joo YE; Chay KO; Kim KK; Jung YD
    Mol Cell Biochem; 2015 Jan; 398(1-2):147-56. PubMed ID: 25234193
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Significant association of Rho/ROCK pathway with invasion and metastasis of bladder cancer.
    Kamai T; Tsujii T; Arai K; Takagi K; Asami H; Ito Y; Oshima H
    Clin Cancer Res; 2003 Jul; 9(7):2632-41. PubMed ID: 12855641
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Benzyl isothiocyanate (BITC) inhibits migration and invasion of human gastric cancer AGS cells via suppressing ERK signal pathways.
    Ho CC; Lai KC; Hsu SC; Kuo CL; Ma CY; Lin ML; Yang JS; Chung JG
    Hum Exp Toxicol; 2011 Apr; 30(4):296-306. PubMed ID: 20498032
    [TBL] [Abstract][Full Text] [Related]  

  • 20. RhoA regulates G1-S progression of gastric cancer cells by modulation of multiple INK4 family tumor suppressors.
    Zhang S; Tang Q; Xu F; Xue Y; Zhen Z; Deng Y; Liu M; Chen J; Liu S; Qiu M; Liao Z; Li Z; Luo D; Shi F; Zheng Y; Bi F
    Mol Cancer Res; 2009 Apr; 7(4):570-80. PubMed ID: 19372585
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.